Our Love-Hate Relationship With Pharmaceuticals

How did we get into this mess that produces untold suffering, impedes effective health care, and costs our economy sacks of bullion and lost productivity?
This post was published on the now-closed HuffPost Contributor platform. Contributors control their own work and posted freely to our site. If you need to flag this entry as abusive, send us an email.

Death Is Not The End

Have you heard this TV ad? Considering a malpractice suit beyond the grave? It's a contrast with the drug advertisments whose promises of vanquished suffering end with fast talking announcers spitting out potential "side effects" including death, followed by the ever present legal catch: "Ask your doctor."

Yes, that's my favorite -- ask your doctor about the 176 possible side effects of the drug that costs 34 times as much as the one it claims to better. And if in your afterlife you check the internet on legal recourse, lists will appear, columned by each individual drug deemed harmful and indexing the many legal teams at hire. There are also stimulating stories of payouts, starting with $15 million or more, briefly describing the cases and adding details explaining how you, too, might win the drug lawsuit lottery.

How did we get into this mess that produces untold suffering, impedes effective health care, and costs our economy sacks of bullion and lost productivity?

Drugs And Movies

Remember the days of "ethical drug companies"? That was before movies like the "Fugitive" where vascular surgeon Dr. Richard Kimble (Harrison Ford) is framed for his wife's murder to prevent the public knowing the new cardiovascular blockbuster "Trivasic" causes liver failure. Sadly the film was prescient (if not quite a blockbuster), appearing years before the Vioxx scandal demonstrated how far a company would go to hide data and protect billions in profits.

Things Did Not Start Out That Way

In the '70s and '80s, drug companies learned -- as did movie companies -- that "blockbusters" earned them so much money, especially in the super profitable U.S. market, that even lowly executives could buy a home in Palm Beach. The strategy was to spend the tens of billions of profit on R&D, and somewhere, somehow, a big new drug will come.

The Glory Days Did Not Last

The vastly complex information system that is the human body suddenly seemed much harder to crack. Drugs that worked beautifully in the lab, superbly in animals and admirably in early drug trials, turned out to have ugly side effects that washed all the costly efforts out to sea. The number of new, approved drugs plummeted.

The companies fought back to retain profits and stock market confidence. Though they kept up massive spending on R&D, executives realized what could not be achieved in the lab might be achieved through marketing and lobbying. Individuals doctors were deluged with drug reps, who changed from experienced pharmacists and nurses to young people so pretty they could work as models or Hollywood starlets; the trend eventually became hiring upbeat college cheerleaders.

Academic physicians, watching their research budgets decline, signed up to run drug company studies and then sometimes stayed on to become well reimbursed flacks who pushed the drugs they were researching to other physicians during orchestrated road shows. Such "opinion leaders" included a well known Duke researcher who told me during the last drug company lecture I ever attended that statins had "virtually no side effects" and could be used in "everybody" -- and said it with a straight face. Statins can be incredibly useful, but I believe that was baldfaced lying.

Then it was on to Congress, which not only passed a bill declaring that Medicare could not bargain with drug companies over price -- legally mandating you and I to pay vastly more than we would in most other developed countries -- but also created a Medicare drug benefit. It is this benefit that is now one of the major entitlements promising to eventually bankrupt Medicare and the federal government.

Government lobbying could go just so far. When Vioxx and Phen-fen and others turned out to have fatal side effects, most companies argued that fines and lawsuits were still far less than billions in profits -- just another cost of doing business.

Where We Are Now

Our love-hate relationship with drugs is a hive of contradictions. We want doctor-prescribed drugs that work, but when they don't we're often furious -- stuff that expensive should be as effective as the company ads say it will be! We often turn to herbal supplements instead, which often are uncontrolled, have side effects, frequently do not contain what they claim and are often marketed to fool people into thinking they're eating food instead of drugs.

Meanwhile, the fascination with drugs has lessened our reliance on non-pharmacologic therapies. Myself and many colleagues of mine have met numerous patients claiming "I can eat what I want" because the statins keep cholesterol level low -- as if cholesterol was the only one of the 700-800 cardiac risk factors that counted.

What We Should Recognize

1. Health, not health care, should be the concern of national policy.

2. Drugs always have side effects. One of the "safest" American drugs, Tylenol, is rarely used or banned throughout much of Europe because of overdoses causing liver failure.

3. The present lottery of drug malpractice attends to public health disasters after the fact, enriches lawyers and a very few suffering families, terrifies physicians into expensive, defensive medicine and has not stopped companies from hiding unwelcome data.

What Should You Do Personally?

When a doctor prescribes a drug, ask questions. Recognize that drug ads may neglect describing much less expensive generics that do the job. Understand that medical miracles happen more commonly in movies more than real life. Understand that illness is complex and difficult -- a major failure of the body to regenerate itself -- and often requires changes in lifestyle to overcome.

And eventually we can do what most of the developed world has done -- develop committees on efficacy helping to decide whether national health services should pay for new drugs.

When you spend your money, you need to think about what you'll get -- and all the costs.

We should be using our heads, reviewing what we can about drugs by ourselves and then calling the doctor.

Popular in the Community

Close

HuffPost Shopping’s Best Finds

MORE IN LIFE